161 related articles for article (PubMed ID: 14748746)
1. Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis.
Ahn WS; Kim KW; Bae SM; Yoon JH; Lee JM; Namkoong SE; Kim JH; Kim CK; Lee YJ; Kim YW
Int J Exp Pathol; 2003 Dec; 84(6):267-79. PubMed ID: 14748746
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling of the cellular processes in uterine leiomyomas: omic approaches and IGF-2 association with leiomyosarcomas.
Bae SM; Kim YW; Lee JM; Namkoong SE; Kim CK; Ahn WS
Cancer Res Treat; 2004 Feb; 36(1):31-42. PubMed ID: 20396563
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells.
Ling J; Wu X; Fu Z; Tan J; Xu Q
Biomed Pharmacother; 2015 Oct; 75():226-33. PubMed ID: 26311392
[TBL] [Abstract][Full Text] [Related]
4. Microarray study of gene expression in uterine leiomyoma.
Litovkin KV; Ivanova OV; Bauer A; Hoheisel JD; Bubnov VV; Zaporozhan VN
Exp Oncol; 2008 Jun; 30(2):106-11. PubMed ID: 18566572
[TBL] [Abstract][Full Text] [Related]
5. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids.
Catherino WH; Leppert PC; Stenmark MH; Payson M; Potlog-Nahari C; Nieman LK; Segars JH
Genes Chromosomes Cancer; 2004 Jul; 40(3):204-17. PubMed ID: 15139000
[TBL] [Abstract][Full Text] [Related]
6. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
7. PEP-19 overexpression in human uterine leiomyoma.
Kanamori T; Takakura K; Mandai M; Kariya M; Fukuhara K; Kusakari T; Momma C; Shime H; Yagi H; Konishi M; Suzuki A; Matsumura N; Nanbu K; Fujita J; Fujii S
Mol Hum Reprod; 2003 Nov; 9(11):709-17. PubMed ID: 14561813
[TBL] [Abstract][Full Text] [Related]
8. A Proteomic Approach for the Identification of Up-Regulated Proteins Involved in the Metabolic Process of the Leiomyoma.
Ura B; Scrimin F; Arrigoni G; Franchin C; Monasta L; Ricci G
Int J Mol Sci; 2016 Apr; 17(4):540. PubMed ID: 27070597
[TBL] [Abstract][Full Text] [Related]
9. Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays.
Malik M; Catherino WH
Fertil Steril; 2007 May; 87(5):1166-72. PubMed ID: 17222838
[TBL] [Abstract][Full Text] [Related]
10. Interactome Analysis of the Differentially Expressed Proteins in Uterine Leiomyoma.
Sahar T; Nigam A; Anjum S; Waziri F; Biswas S; Jain SK; Wajid S
Anticancer Agents Med Chem; 2019; 19(10):1293-1312. PubMed ID: 30727917
[TBL] [Abstract][Full Text] [Related]
11. Profiling of differentially expressed genes in human uterine leiomyomas.
Lee EJ; Kong G; Lee SH; Rho SB; Park CS; Kim BG; Bae DS; Kavanagh JJ; Lee JH
Int J Gynecol Cancer; 2005; 15(1):146-54. PubMed ID: 15670310
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
[TBL] [Abstract][Full Text] [Related]
13. The influence of phenolic environmental estrogen on the transcriptome of uterine leiomyoma cells: A whole transcriptome profiling-based analysis.
Li Z; Yin H; Shen Y; Ren M; Xu X
Ecotoxicol Environ Saf; 2021 Mar; 211():111945. PubMed ID: 33516137
[TBL] [Abstract][Full Text] [Related]
14. PLIN2 Functions As a Novel Link Between Progesterone Signaling and Metabolism in Uterine Leiomyoma Cells.
Okeigwe I; Bulun S; Liu S; Rademaker AW; Coon JS; Kujawa S; Robins J; Yin P
J Clin Endocrinol Metab; 2019 Dec; 104(12):6256-6264. PubMed ID: 31504629
[TBL] [Abstract][Full Text] [Related]
15. Expression Profiling of lncRNAs, miRNAs, and mRNAs and Their Differential Expression in Leiomyoma Using Next-Generation RNA Sequencing.
Chuang TD; Khorram O
Reprod Sci; 2018 Feb; 25(2):246-255. PubMed ID: 28587571
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.
Swartz CD; Afshari CA; Yu L; Hall KE; Dixon D
Mol Hum Reprod; 2005 Jun; 11(6):441-50. PubMed ID: 15879465
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Verala J; Luo X; Xu J; Williams RS
J Soc Gynecol Investig; 2003 Apr; 10(3):161-71. PubMed ID: 12699880
[TBL] [Abstract][Full Text] [Related]
20. Two-dimensional gel electrophoresis analysis of the leiomyoma interstitial fluid reveals altered protein expression with a possible involvement in pathogenesis.
Ura B; Scrimin F; Zanconati F; Arrigoni G; Monasta L; Romano A; Banco R; Zweyer M; Milani D; Ricci G
Oncol Rep; 2015 May; 33(5):2219-26. PubMed ID: 25738828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
